Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bausch Health Companies Inc (BHC)

18.36   0.36 (2%) 10-23 23:37
Open: 18.13 Pre. Close: 18
High: 18.42 Low: 17.81
Volume: 3,160,986 Market Cap: 6,518M
Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. The company is headquartered in Laval, Quebec and currently employs 21,100 full-time employees. The company primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. The company also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 18.442 - 18.513 18.513 - 18.584
Low: 17.625 - 17.709 17.709 - 17.794
Close: 18.222 - 18.353 18.353 - 18.484

Technical analysis

as of: 2020-10-23 4:41:10 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 21.51     One year: 25.13
Support: Support1: 16.22    Support2: 14.86
Resistance: Resistance1: 18.42    Resistance2: 21.51
Pivot: 17.11
Moving Average: MA(5): 17.63     MA(20): 16.70
MA(100): 17.51     MA(250): 20.95
MACD: MACD(12,26): 0.40     Signal(9): 0.22
Stochastic oscillator: %K(14,3): 87.31     %D(3): 76.93
RSI: RSI(14): 63.15
52-week: High: 31.97  Low: 11.15  Change(%): -23.7
Average Vol(K): 3-Month: 451042  10-Days: 300311

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
BHC has closed below upper band by 9.6%. Bollinger Bands are 6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 23 Oct 2020
Q4 2020 Earnings Estimate for Bausch Health Companies Inc (NYSE:BHC) Issued By Piper Sandler - MarketBeat

Thu, 22 Oct 2020
The Rejuvenation of Bausch Health Companies Inc. (NYSE:BHC) - The Oracle Dispatch

Wed, 21 Oct 2020
Where Does Bausch Health Companies Inc (BHC) Stock Fall in the Drug Manufacturers - Specialty & Generic Field? - InvestorsObserver

Wed, 21 Oct 2020
Bausch Health Companies Inc. (NYSE:BHC) surprises Wall Street with -1.1% stock price loss - Marketing Sentinel

Tue, 13 Oct 2020
Bausch Health Companies (NYSE:BHC) Stock Rating Lowered by Zacks Investment Research - MarketBeat

Mon, 12 Oct 2020
Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12 - PRNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 355
Shares Float (M) 309
% Held by Insiders 0.55
% Held by Institutions 66.95
Shares Short (K) 16,500
Shares Short P. Month (K) 17,790

Stock Financials

EPS -5.780
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.340
Profit Margin -25.19
Operating Margin 14.08
Return on Assets (ttm) 2.2
Return on Equity (ttm) -126.3
Qtrly Rev. Growth -22.7
Gross Profit (p.s.) 17.606
Sales Per Share 22.846
EBITDA (p.s.) 8.789
Qtrly Earnings Growth
Operating Cash Flow (M) 1,210
Levered Free Cash Flow (M) 1,880

Stock Valuations

PE Ratio -3.18
PEG Ratio
Price to Book value 13.70
Price to Sales 0.80
Price to Cash Flow 5.39

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 2010-11-09
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.